Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
International Journal of Dermatology2017Vol. 56(8), pp. 833–835
Citations Over TimeTop 10% of 2017 papers
Abstract
Ruxolitinib should be considered for cases of unresponsive alopecia in the community.
Related Papers
- → Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata(2016)284 cited
- → Ruxolitinib for the treatment of severe alopecia areata(2018)47 cited
- [Furalen in the treatment of alopecia areata and vitiligo].(1972)